nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—CYP2A6—Fluorouracil—colon cancer	0.0968	0.14	CbGbCtD
Ifosfamide—CYP3A7—Irinotecan—colon cancer	0.0689	0.0995	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0689	0.0995	CbGbCtD
Ifosfamide—CYP2B6—Irinotecan—colon cancer	0.0657	0.0948	CbGbCtD
Ifosfamide—CYP3A7—Vincristine—colon cancer	0.0603	0.087	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0603	0.087	CbGbCtD
Ifosfamide—CYP2C9—Capecitabine—colon cancer	0.0561	0.081	CbGbCtD
Ifosfamide—CYP3A5—Irinotecan—colon cancer	0.0517	0.0747	CbGbCtD
Ifosfamide—CYP2C8—Fluorouracil—colon cancer	0.0477	0.0689	CbGbCtD
Ifosfamide—CYP3A5—Vincristine—colon cancer	0.0452	0.0653	CbGbCtD
Ifosfamide—CYP2C9—Fluorouracil—colon cancer	0.0333	0.0481	CbGbCtD
Ifosfamide—CYP3A4—Irinotecan—colon cancer	0.0202	0.0291	CbGbCtD
Ifosfamide—CYP3A4—Vincristine—colon cancer	0.0176	0.0254	CbGbCtD
Ifosfamide—Cyclophosphamide—ABCB1—colon cancer	0.00251	1	CrCbGaD
Ifosfamide—CYP2C18—digestive system—colon cancer	0.000655	0.0667	CbGeAlD
Ifosfamide—CYP2C18—vagina—colon cancer	0.000579	0.0589	CbGeAlD
Ifosfamide—PTGS1—endothelium—colon cancer	0.000577	0.0588	CbGeAlD
Ifosfamide—PTGS1—blood vessel—colon cancer	0.000532	0.0542	CbGeAlD
Ifosfamide—CYP2C18—liver—colon cancer	0.000488	0.0497	CbGeAlD
Ifosfamide—CYP3A7—liver—colon cancer	0.000464	0.0473	CbGeAlD
Ifosfamide—CYP3A7-CYP3A51P—liver—colon cancer	0.000395	0.0402	CbGeAlD
Ifosfamide—CYP2A6—vagina—colon cancer	0.000382	0.0389	CbGeAlD
Ifosfamide—Anaemia—Fluorouracil—colon cancer	0.000325	0.0011	CcSEcCtD
Ifosfamide—CYP2A6—liver—colon cancer	0.000323	0.0329	CbGeAlD
Ifosfamide—Myalgia—Vincristine—colon cancer	0.000321	0.00109	CcSEcCtD
Ifosfamide—Cough—Irinotecan—colon cancer	0.000321	0.00109	CcSEcCtD
Ifosfamide—Hyperglycaemia—Capecitabine—colon cancer	0.000318	0.00108	CcSEcCtD
Ifosfamide—Hypertension—Irinotecan—colon cancer	0.000317	0.00108	CcSEcCtD
Ifosfamide—Pneumonia—Capecitabine—colon cancer	0.000316	0.00107	CcSEcCtD
Ifosfamide—Leukopenia—Fluorouracil—colon cancer	0.000315	0.00107	CcSEcCtD
Ifosfamide—Infestation NOS—Capecitabine—colon cancer	0.000315	0.00107	CcSEcCtD
Ifosfamide—Infestation—Capecitabine—colon cancer	0.000315	0.00107	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000312	0.00106	CcSEcCtD
Ifosfamide—Acute coronary syndrome—Capecitabine—colon cancer	0.00031	0.00105	CcSEcCtD
Ifosfamide—Renal failure—Capecitabine—colon cancer	0.000309	0.00105	CcSEcCtD
Ifosfamide—Discomfort—Irinotecan—colon cancer	0.000309	0.00105	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Capecitabine—colon cancer	0.000308	0.00105	CcSEcCtD
Ifosfamide—Myocardial infarction—Capecitabine—colon cancer	0.000308	0.00105	CcSEcCtD
Ifosfamide—Oedema—Vincristine—colon cancer	0.000308	0.00104	CcSEcCtD
Ifosfamide—Anaphylactic shock—Vincristine—colon cancer	0.000308	0.00104	CcSEcCtD
Ifosfamide—Stomatitis—Capecitabine—colon cancer	0.000307	0.00104	CcSEcCtD
Ifosfamide—Infection—Vincristine—colon cancer	0.000306	0.00104	CcSEcCtD
Ifosfamide—Conjunctivitis—Capecitabine—colon cancer	0.000306	0.00104	CcSEcCtD
Ifosfamide—Convulsion—Fluorouracil—colon cancer	0.000305	0.00103	CcSEcCtD
Ifosfamide—Osteoarthritis—Methotrexate—colon cancer	0.000304	0.00103	CcSEcCtD
Ifosfamide—Confusional state—Irinotecan—colon cancer	0.000302	0.00103	CcSEcCtD
Ifosfamide—Nervous system disorder—Vincristine—colon cancer	0.000302	0.00102	CcSEcCtD
Ifosfamide—Thrombocytopenia—Vincristine—colon cancer	0.000301	0.00102	CcSEcCtD
Ifosfamide—Haematuria—Capecitabine—colon cancer	0.0003	0.00102	CcSEcCtD
Ifosfamide—Anaphylactic shock—Irinotecan—colon cancer	0.0003	0.00102	CcSEcCtD
Ifosfamide—Oedema—Irinotecan—colon cancer	0.0003	0.00102	CcSEcCtD
Ifosfamide—Myalgia—Fluorouracil—colon cancer	0.0003	0.00102	CcSEcCtD
Ifosfamide—Chest pain—Fluorouracil—colon cancer	0.0003	0.00102	CcSEcCtD
Ifosfamide—Infection—Irinotecan—colon cancer	0.000298	0.00101	CcSEcCtD
Ifosfamide—Hyperhidrosis—Vincristine—colon cancer	0.000298	0.00101	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Capecitabine—colon cancer	0.000298	0.00101	CcSEcCtD
Ifosfamide—CYP2C8—renal system—colon cancer	0.000296	0.0302	CbGeAlD
Ifosfamide—Discomfort—Fluorouracil—colon cancer	0.000296	0.001	CcSEcCtD
Ifosfamide—Nervous system disorder—Irinotecan—colon cancer	0.000294	0.000997	CcSEcCtD
Ifosfamide—Agranulocytosis—Capecitabine—colon cancer	0.000294	0.000996	CcSEcCtD
Ifosfamide—Thrombocytopenia—Irinotecan—colon cancer	0.000294	0.000995	CcSEcCtD
Ifosfamide—Anorexia—Vincristine—colon cancer	0.000293	0.000995	CcSEcCtD
Ifosfamide—Hyperhidrosis—Irinotecan—colon cancer	0.00029	0.000983	CcSEcCtD
Ifosfamide—Confusional state—Fluorouracil—colon cancer	0.00029	0.000982	CcSEcCtD
Ifosfamide—Hypotension—Vincristine—colon cancer	0.000288	0.000975	CcSEcCtD
Ifosfamide—Bradycardia—Capecitabine—colon cancer	0.000288	0.000975	CcSEcCtD
Ifosfamide—Oedema—Fluorouracil—colon cancer	0.000287	0.000974	CcSEcCtD
Ifosfamide—Anaphylactic shock—Fluorouracil—colon cancer	0.000287	0.000974	CcSEcCtD
Ifosfamide—Anorexia—Irinotecan—colon cancer	0.000286	0.000969	CcSEcCtD
Ifosfamide—Infection—Fluorouracil—colon cancer	0.000285	0.000967	CcSEcCtD
Ifosfamide—Haemoglobin—Capecitabine—colon cancer	0.000284	0.000963	CcSEcCtD
Ifosfamide—Hepatitis—Capecitabine—colon cancer	0.000282	0.000958	CcSEcCtD
Ifosfamide—Haemorrhage—Capecitabine—colon cancer	0.000282	0.000958	CcSEcCtD
Ifosfamide—Nervous system disorder—Fluorouracil—colon cancer	0.000282	0.000955	CcSEcCtD
Ifosfamide—Thrombocytopenia—Fluorouracil—colon cancer	0.000281	0.000953	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Vincristine—colon cancer	0.000281	0.000951	CcSEcCtD
Ifosfamide—Hypotension—Irinotecan—colon cancer	0.00028	0.00095	CcSEcCtD
Ifosfamide—Urinary tract disorder—Capecitabine—colon cancer	0.000279	0.000946	CcSEcCtD
Ifosfamide—CYP2C19—digestive system—colon cancer	0.000279	0.0284	CbGeAlD
Ifosfamide—Connective tissue disorder—Capecitabine—colon cancer	0.000278	0.000941	CcSEcCtD
Ifosfamide—Urethral disorder—Capecitabine—colon cancer	0.000277	0.000939	CcSEcCtD
Ifosfamide—Paraesthesia—Vincristine—colon cancer	0.000276	0.000937	CcSEcCtD
Ifosfamide—Breast disorder—Methotrexate—colon cancer	0.000275	0.000931	CcSEcCtD
Ifosfamide—Anorexia—Fluorouracil—colon cancer	0.000274	0.000928	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000274	0.000928	CcSEcCtD
Ifosfamide—Visual impairment—Capecitabine—colon cancer	0.000272	0.000923	CcSEcCtD
Ifosfamide—Paraesthesia—Irinotecan—colon cancer	0.000269	0.000913	CcSEcCtD
Ifosfamide—Hypotension—Fluorouracil—colon cancer	0.000268	0.00091	CcSEcCtD
Ifosfamide—Decreased appetite—Vincristine—colon cancer	0.000268	0.000907	CcSEcCtD
Ifosfamide—CYP3A5—renal system—colon cancer	0.000268	0.0272	CbGeAlD
Ifosfamide—Dyspnoea—Irinotecan—colon cancer	0.000267	0.000906	CcSEcCtD
Ifosfamide—Erythema multiforme—Capecitabine—colon cancer	0.000267	0.000905	CcSEcCtD
Ifosfamide—Somnolence—Irinotecan—colon cancer	0.000267	0.000904	CcSEcCtD
Ifosfamide—CYP2B6—renal system—colon cancer	0.000266	0.0271	CbGeAlD
Ifosfamide—Gastrointestinal disorder—Vincristine—colon cancer	0.000266	0.000901	CcSEcCtD
Ifosfamide—Fatigue—Vincristine—colon cancer	0.000265	0.0009	CcSEcCtD
Ifosfamide—Eye disorder—Capecitabine—colon cancer	0.000264	0.000895	CcSEcCtD
Ifosfamide—Tinnitus—Capecitabine—colon cancer	0.000263	0.000893	CcSEcCtD
Ifosfamide—Pain—Vincristine—colon cancer	0.000263	0.000893	CcSEcCtD
Ifosfamide—Constipation—Vincristine—colon cancer	0.000263	0.000893	CcSEcCtD
Ifosfamide—Flushing—Capecitabine—colon cancer	0.000262	0.000889	CcSEcCtD
Ifosfamide—Cardiac disorder—Capecitabine—colon cancer	0.000262	0.000889	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000262	0.000887	CcSEcCtD
Ifosfamide—Decreased appetite—Irinotecan—colon cancer	0.000261	0.000884	CcSEcCtD
Ifosfamide—PTGS1—epithelium—colon cancer	0.000259	0.0264	CbGeAlD
Ifosfamide—Gastrointestinal disorder—Irinotecan—colon cancer	0.000259	0.000878	CcSEcCtD
Ifosfamide—Fatigue—Irinotecan—colon cancer	0.000259	0.000876	CcSEcCtD
Ifosfamide—Paraesthesia—Fluorouracil—colon cancer	0.000258	0.000874	CcSEcCtD
Ifosfamide—Pancreatitis—Methotrexate—colon cancer	0.000258	0.000873	CcSEcCtD
Ifosfamide—Pain—Irinotecan—colon cancer	0.000256	0.000869	CcSEcCtD
Ifosfamide—Constipation—Irinotecan—colon cancer	0.000256	0.000869	CcSEcCtD
Ifosfamide—Angiopathy—Capecitabine—colon cancer	0.000256	0.000869	CcSEcCtD
Ifosfamide—Dyspnoea—Fluorouracil—colon cancer	0.000256	0.000868	CcSEcCtD
Ifosfamide—Somnolence—Fluorouracil—colon cancer	0.000255	0.000866	CcSEcCtD
Ifosfamide—Immune system disorder—Capecitabine—colon cancer	0.000255	0.000865	CcSEcCtD
Ifosfamide—Mediastinal disorder—Capecitabine—colon cancer	0.000255	0.000863	CcSEcCtD
Ifosfamide—Chills—Capecitabine—colon cancer	0.000253	0.000859	CcSEcCtD
Ifosfamide—Arrhythmia—Capecitabine—colon cancer	0.000252	0.000856	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Vincristine—colon cancer	0.000252	0.000854	CcSEcCtD
Ifosfamide—PTGS1—smooth muscle tissue—colon cancer	0.00025	0.0254	CbGeAlD
Ifosfamide—Decreased appetite—Fluorouracil—colon cancer	0.00025	0.000846	CcSEcCtD
Ifosfamide—Alopecia—Capecitabine—colon cancer	0.00025	0.000846	CcSEcCtD
Ifosfamide—Pancytopenia—Methotrexate—colon cancer	0.000249	0.000846	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000248	0.000841	CcSEcCtD
Ifosfamide—Mental disorder—Capecitabine—colon cancer	0.000247	0.000839	CcSEcCtD
Ifosfamide—Feeling abnormal—Irinotecan—colon cancer	0.000247	0.000838	CcSEcCtD
Ifosfamide—CYP2C19—vagina—colon cancer	0.000246	0.025	CbGeAlD
Ifosfamide—Erythema—Capecitabine—colon cancer	0.000246	0.000834	CcSEcCtD
Ifosfamide—Malnutrition—Capecitabine—colon cancer	0.000246	0.000834	CcSEcCtD
Ifosfamide—Dysuria—Methotrexate—colon cancer	0.000246	0.000833	CcSEcCtD
Ifosfamide—Pain—Fluorouracil—colon cancer	0.000246	0.000833	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Irinotecan—colon cancer	0.000245	0.000831	CcSEcCtD
Ifosfamide—Abdominal pain—Vincristine—colon cancer	0.000243	0.000825	CcSEcCtD
Ifosfamide—Body temperature increased—Vincristine—colon cancer	0.000243	0.000825	CcSEcCtD
Ifosfamide—PTGS1—renal system—colon cancer	0.00024	0.0245	CbGeAlD
Ifosfamide—Body temperature increased—Irinotecan—colon cancer	0.000237	0.000804	CcSEcCtD
Ifosfamide—Abdominal pain—Irinotecan—colon cancer	0.000237	0.000804	CcSEcCtD
Ifosfamide—Feeling abnormal—Fluorouracil—colon cancer	0.000237	0.000802	CcSEcCtD
Ifosfamide—Pneumonia—Methotrexate—colon cancer	0.000236	0.000799	CcSEcCtD
Ifosfamide—Infestation NOS—Methotrexate—colon cancer	0.000234	0.000794	CcSEcCtD
Ifosfamide—Infestation—Methotrexate—colon cancer	0.000234	0.000794	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000232	0.000787	CcSEcCtD
Ifosfamide—Vision blurred—Capecitabine—colon cancer	0.000232	0.000786	CcSEcCtD
Ifosfamide—Renal failure—Methotrexate—colon cancer	0.00023	0.000781	CcSEcCtD
Ifosfamide—Stomatitis—Methotrexate—colon cancer	0.000228	0.000774	CcSEcCtD
Ifosfamide—Ill-defined disorder—Capecitabine—colon cancer	0.000228	0.000773	CcSEcCtD
Ifosfamide—Urticaria—Fluorouracil—colon cancer	0.000228	0.000773	CcSEcCtD
Ifosfamide—Conjunctivitis—Methotrexate—colon cancer	0.000228	0.000772	CcSEcCtD
Ifosfamide—Anaemia—Capecitabine—colon cancer	0.000227	0.000771	CcSEcCtD
Ifosfamide—Body temperature increased—Fluorouracil—colon cancer	0.000227	0.00077	CcSEcCtD
Ifosfamide—Hypersensitivity—Vincristine—colon cancer	0.000227	0.000769	CcSEcCtD
Ifosfamide—Haematuria—Methotrexate—colon cancer	0.000223	0.000757	CcSEcCtD
Ifosfamide—Malaise—Capecitabine—colon cancer	0.000222	0.000752	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Methotrexate—colon cancer	0.000222	0.000751	CcSEcCtD
Ifosfamide—Vertigo—Capecitabine—colon cancer	0.000221	0.000749	CcSEcCtD
Ifosfamide—Hypersensitivity—Irinotecan—colon cancer	0.000221	0.000749	CcSEcCtD
Ifosfamide—Asthenia—Vincristine—colon cancer	0.000221	0.000749	CcSEcCtD
Ifosfamide—CYP2B6—lymphoid tissue—colon cancer	0.000221	0.0225	CbGeAlD
Ifosfamide—Leukopenia—Capecitabine—colon cancer	0.00022	0.000746	CcSEcCtD
Ifosfamide—CYP3A5—digestive system—colon cancer	0.000219	0.0223	CbGeAlD
Ifosfamide—Agranulocytosis—Methotrexate—colon cancer	0.000219	0.000741	CcSEcCtD
Ifosfamide—CYP2B6—digestive system—colon cancer	0.000218	0.0222	CbGeAlD
Ifosfamide—Palpitations—Capecitabine—colon cancer	0.000217	0.000737	CcSEcCtD
Ifosfamide—CYP2C9—digestive system—colon cancer	0.000216	0.022	CbGeAlD
Ifosfamide—Asthenia—Irinotecan—colon cancer	0.000215	0.000729	CcSEcCtD
Ifosfamide—CYP2C8—vagina—colon cancer	0.000215	0.0219	CbGeAlD
Ifosfamide—Cough—Capecitabine—colon cancer	0.000215	0.000727	CcSEcCtD
Ifosfamide—Hypertension—Capecitabine—colon cancer	0.000212	0.00072	CcSEcCtD
Ifosfamide—Hypersensitivity—Fluorouracil—colon cancer	0.000212	0.000717	CcSEcCtD
Ifosfamide—Haemoglobin—Methotrexate—colon cancer	0.000211	0.000717	CcSEcCtD
Ifosfamide—Diarrhoea—Vincristine—colon cancer	0.000211	0.000714	CcSEcCtD
Ifosfamide—Hepatitis—Methotrexate—colon cancer	0.00021	0.000713	CcSEcCtD
Ifosfamide—Haemorrhage—Methotrexate—colon cancer	0.00021	0.000713	CcSEcCtD
Ifosfamide—Arthralgia—Capecitabine—colon cancer	0.000209	0.00071	CcSEcCtD
Ifosfamide—Myalgia—Capecitabine—colon cancer	0.000209	0.00071	CcSEcCtD
Ifosfamide—Chest pain—Capecitabine—colon cancer	0.000209	0.00071	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000208	0.000705	CcSEcCtD
Ifosfamide—Urinary tract disorder—Methotrexate—colon cancer	0.000208	0.000704	CcSEcCtD
Ifosfamide—CYP2C19—liver—colon cancer	0.000207	0.0211	CbGeAlD
Ifosfamide—Discomfort—Capecitabine—colon cancer	0.000207	0.000701	CcSEcCtD
Ifosfamide—Urethral disorder—Methotrexate—colon cancer	0.000206	0.000699	CcSEcCtD
Ifosfamide—Diarrhoea—Irinotecan—colon cancer	0.000205	0.000696	CcSEcCtD
Ifosfamide—Dizziness—Vincristine—colon cancer	0.000204	0.00069	CcSEcCtD
Ifosfamide—Pruritus—Fluorouracil—colon cancer	0.000203	0.000689	CcSEcCtD
Ifosfamide—Visual impairment—Methotrexate—colon cancer	0.000203	0.000687	CcSEcCtD
Ifosfamide—Confusional state—Capecitabine—colon cancer	0.000202	0.000686	CcSEcCtD
Ifosfamide—CYP3A4—renal system—colon cancer	0.000201	0.0204	CbGeAlD
Ifosfamide—Oedema—Capecitabine—colon cancer	0.000201	0.00068	CcSEcCtD
Ifosfamide—Infection—Capecitabine—colon cancer	0.000199	0.000676	CcSEcCtD
Ifosfamide—Erythema multiforme—Methotrexate—colon cancer	0.000199	0.000674	CcSEcCtD
Ifosfamide—Dizziness—Irinotecan—colon cancer	0.000198	0.000672	CcSEcCtD
Ifosfamide—PTGS1—digestive system—colon cancer	0.000197	0.0201	CbGeAlD
Ifosfamide—Nervous system disorder—Capecitabine—colon cancer	0.000197	0.000667	CcSEcCtD
Ifosfamide—Eye disorder—Methotrexate—colon cancer	0.000197	0.000666	CcSEcCtD
Ifosfamide—Diarrhoea—Fluorouracil—colon cancer	0.000196	0.000666	CcSEcCtD
Ifosfamide—Thrombocytopenia—Capecitabine—colon cancer	0.000196	0.000666	CcSEcCtD
Ifosfamide—Tinnitus—Methotrexate—colon cancer	0.000196	0.000665	CcSEcCtD
Ifosfamide—Vomiting—Vincristine—colon cancer	0.000196	0.000664	CcSEcCtD
Ifosfamide—Cardiac disorder—Methotrexate—colon cancer	0.000195	0.000662	CcSEcCtD
Ifosfamide—Skin disorder—Capecitabine—colon cancer	0.000195	0.000661	CcSEcCtD
Ifosfamide—Rash—Vincristine—colon cancer	0.000194	0.000658	CcSEcCtD
Ifosfamide—Hyperhidrosis—Capecitabine—colon cancer	0.000194	0.000658	CcSEcCtD
Ifosfamide—Dermatitis—Vincristine—colon cancer	0.000194	0.000658	CcSEcCtD
Ifosfamide—CYP3A5—vagina—colon cancer	0.000194	0.0197	CbGeAlD
Ifosfamide—CYP2B6—vagina—colon cancer	0.000193	0.0196	CbGeAlD
Ifosfamide—Anorexia—Capecitabine—colon cancer	0.000191	0.000649	CcSEcCtD
Ifosfamide—Angiopathy—Methotrexate—colon cancer	0.000191	0.000647	CcSEcCtD
Ifosfamide—Vomiting—Irinotecan—colon cancer	0.000191	0.000646	CcSEcCtD
Ifosfamide—Immune system disorder—Methotrexate—colon cancer	0.00019	0.000644	CcSEcCtD
Ifosfamide—Dizziness—Fluorouracil—colon cancer	0.00019	0.000644	CcSEcCtD
Ifosfamide—Mediastinal disorder—Methotrexate—colon cancer	0.00019	0.000643	CcSEcCtD
Ifosfamide—Rash—Irinotecan—colon cancer	0.000189	0.000641	CcSEcCtD
Ifosfamide—Dermatitis—Irinotecan—colon cancer	0.000189	0.00064	CcSEcCtD
Ifosfamide—Chills—Methotrexate—colon cancer	0.000189	0.00064	CcSEcCtD
Ifosfamide—Hypotension—Capecitabine—colon cancer	0.000188	0.000636	CcSEcCtD
Ifosfamide—Alopecia—Methotrexate—colon cancer	0.000186	0.00063	CcSEcCtD
Ifosfamide—Mental disorder—Methotrexate—colon cancer	0.000184	0.000625	CcSEcCtD
Ifosfamide—Malnutrition—Methotrexate—colon cancer	0.000183	0.000621	CcSEcCtD
Ifosfamide—Erythema—Methotrexate—colon cancer	0.000183	0.000621	CcSEcCtD
Ifosfamide—Nausea—Vincristine—colon cancer	0.000183	0.00062	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000183	0.00062	CcSEcCtD
Ifosfamide—Vomiting—Fluorouracil—colon cancer	0.000183	0.000619	CcSEcCtD
Ifosfamide—CYP2C8—liver—colon cancer	0.000181	0.0184	CbGeAlD
Ifosfamide—Rash—Fluorouracil—colon cancer	0.000181	0.000614	CcSEcCtD
Ifosfamide—Dermatitis—Fluorouracil—colon cancer	0.000181	0.000613	CcSEcCtD
Ifosfamide—Paraesthesia—Capecitabine—colon cancer	0.00018	0.000611	CcSEcCtD
Ifosfamide—Dyspnoea—Capecitabine—colon cancer	0.000179	0.000607	CcSEcCtD
Ifosfamide—Nausea—Irinotecan—colon cancer	0.000178	0.000604	CcSEcCtD
Ifosfamide—Decreased appetite—Capecitabine—colon cancer	0.000174	0.000591	CcSEcCtD
Ifosfamide—PTGS1—vagina—colon cancer	0.000174	0.0177	CbGeAlD
Ifosfamide—Gastrointestinal disorder—Capecitabine—colon cancer	0.000173	0.000587	CcSEcCtD
Ifosfamide—Fatigue—Capecitabine—colon cancer	0.000173	0.000587	CcSEcCtD
Ifosfamide—Vision blurred—Methotrexate—colon cancer	0.000173	0.000585	CcSEcCtD
Ifosfamide—Constipation—Capecitabine—colon cancer	0.000172	0.000582	CcSEcCtD
Ifosfamide—Pain—Capecitabine—colon cancer	0.000172	0.000582	CcSEcCtD
Ifosfamide—Nausea—Fluorouracil—colon cancer	0.000171	0.000578	CcSEcCtD
Ifosfamide—Ill-defined disorder—Methotrexate—colon cancer	0.00017	0.000576	CcSEcCtD
Ifosfamide—Anaemia—Methotrexate—colon cancer	0.000169	0.000574	CcSEcCtD
Ifosfamide—Feeling abnormal—Capecitabine—colon cancer	0.000165	0.000561	CcSEcCtD
Ifosfamide—Malaise—Methotrexate—colon cancer	0.000165	0.00056	CcSEcCtD
Ifosfamide—CYP3A4—digestive system—colon cancer	0.000165	0.0168	CbGeAlD
Ifosfamide—Vertigo—Methotrexate—colon cancer	0.000164	0.000558	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Capecitabine—colon cancer	0.000164	0.000556	CcSEcCtD
Ifosfamide—Leukopenia—Methotrexate—colon cancer	0.000164	0.000556	CcSEcCtD
Ifosfamide—CYP3A5—liver—colon cancer	0.000163	0.0166	CbGeAlD
Ifosfamide—CYP2B6—liver—colon cancer	0.000162	0.0165	CbGeAlD
Ifosfamide—CYP2C9—liver—colon cancer	0.000161	0.0164	CbGeAlD
Ifosfamide—Cough—Methotrexate—colon cancer	0.00016	0.000542	CcSEcCtD
Ifosfamide—Urticaria—Capecitabine—colon cancer	0.000159	0.000541	CcSEcCtD
Ifosfamide—Body temperature increased—Capecitabine—colon cancer	0.000159	0.000538	CcSEcCtD
Ifosfamide—Abdominal pain—Capecitabine—colon cancer	0.000159	0.000538	CcSEcCtD
Ifosfamide—Convulsion—Methotrexate—colon cancer	0.000159	0.000538	CcSEcCtD
Ifosfamide—Chest pain—Methotrexate—colon cancer	0.000156	0.000528	CcSEcCtD
Ifosfamide—Arthralgia—Methotrexate—colon cancer	0.000156	0.000528	CcSEcCtD
Ifosfamide—Myalgia—Methotrexate—colon cancer	0.000156	0.000528	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000155	0.000525	CcSEcCtD
Ifosfamide—Discomfort—Methotrexate—colon cancer	0.000154	0.000522	CcSEcCtD
Ifosfamide—Confusional state—Methotrexate—colon cancer	0.000151	0.000511	CcSEcCtD
Ifosfamide—Anaphylactic shock—Methotrexate—colon cancer	0.000149	0.000506	CcSEcCtD
Ifosfamide—Infection—Methotrexate—colon cancer	0.000148	0.000503	CcSEcCtD
Ifosfamide—Hypersensitivity—Capecitabine—colon cancer	0.000148	0.000501	CcSEcCtD
Ifosfamide—Nervous system disorder—Methotrexate—colon cancer	0.000147	0.000497	CcSEcCtD
Ifosfamide—Thrombocytopenia—Methotrexate—colon cancer	0.000146	0.000496	CcSEcCtD
Ifosfamide—Skin disorder—Methotrexate—colon cancer	0.000145	0.000492	CcSEcCtD
Ifosfamide—Hyperhidrosis—Methotrexate—colon cancer	0.000144	0.00049	CcSEcCtD
Ifosfamide—Asthenia—Capecitabine—colon cancer	0.000144	0.000488	CcSEcCtD
Ifosfamide—Anorexia—Methotrexate—colon cancer	0.000142	0.000483	CcSEcCtD
Ifosfamide—Pruritus—Capecitabine—colon cancer	0.000142	0.000481	CcSEcCtD
Ifosfamide—Hypotension—Methotrexate—colon cancer	0.00014	0.000473	CcSEcCtD
Ifosfamide—Diarrhoea—Capecitabine—colon cancer	0.000137	0.000466	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000136	0.000461	CcSEcCtD
Ifosfamide—Paraesthesia—Methotrexate—colon cancer	0.000134	0.000455	CcSEcCtD
Ifosfamide—Dyspnoea—Methotrexate—colon cancer	0.000133	0.000452	CcSEcCtD
Ifosfamide—Somnolence—Methotrexate—colon cancer	0.000133	0.00045	CcSEcCtD
Ifosfamide—Dizziness—Capecitabine—colon cancer	0.000133	0.00045	CcSEcCtD
Ifosfamide—Decreased appetite—Methotrexate—colon cancer	0.00013	0.00044	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Methotrexate—colon cancer	0.000129	0.000437	CcSEcCtD
Ifosfamide—Fatigue—Methotrexate—colon cancer	0.000129	0.000437	CcSEcCtD
Ifosfamide—Pain—Methotrexate—colon cancer	0.000128	0.000433	CcSEcCtD
Ifosfamide—Vomiting—Capecitabine—colon cancer	0.000128	0.000433	CcSEcCtD
Ifosfamide—Rash—Capecitabine—colon cancer	0.000127	0.000429	CcSEcCtD
Ifosfamide—Dermatitis—Capecitabine—colon cancer	0.000126	0.000429	CcSEcCtD
Ifosfamide—Feeling abnormal—Methotrexate—colon cancer	0.000123	0.000417	CcSEcCtD
Ifosfamide—CYP3A4—liver—colon cancer	0.000123	0.0125	CbGeAlD
Ifosfamide—Gastrointestinal pain—Methotrexate—colon cancer	0.000122	0.000414	CcSEcCtD
Ifosfamide—Nausea—Capecitabine—colon cancer	0.000119	0.000404	CcSEcCtD
Ifosfamide—Urticaria—Methotrexate—colon cancer	0.000119	0.000402	CcSEcCtD
Ifosfamide—Body temperature increased—Methotrexate—colon cancer	0.000118	0.0004	CcSEcCtD
Ifosfamide—Abdominal pain—Methotrexate—colon cancer	0.000118	0.0004	CcSEcCtD
Ifosfamide—PTGS1—lymph node—colon cancer	0.000113	0.0115	CbGeAlD
Ifosfamide—Hypersensitivity—Methotrexate—colon cancer	0.00011	0.000373	CcSEcCtD
Ifosfamide—Asthenia—Methotrexate—colon cancer	0.000107	0.000363	CcSEcCtD
Ifosfamide—Pruritus—Methotrexate—colon cancer	0.000106	0.000358	CcSEcCtD
Ifosfamide—Diarrhoea—Methotrexate—colon cancer	0.000102	0.000347	CcSEcCtD
Ifosfamide—Dizziness—Methotrexate—colon cancer	9.88e-05	0.000335	CcSEcCtD
Ifosfamide—Vomiting—Methotrexate—colon cancer	9.5e-05	0.000322	CcSEcCtD
Ifosfamide—Rash—Methotrexate—colon cancer	9.42e-05	0.000319	CcSEcCtD
Ifosfamide—Dermatitis—Methotrexate—colon cancer	9.41e-05	0.000319	CcSEcCtD
Ifosfamide—Nausea—Methotrexate—colon cancer	8.87e-05	0.000301	CcSEcCtD
